Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
Open Access
- 8 November 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 2539
Abstract
Aberrations in complement system functions have been identified as either direct or indirect pathophysiological mechanisms in many diseases and pathological conditions, such as infections, autoimmune diseases, inflammation, malignancies, and allogeneic transplantation. Currently available techniques to study complement include quantification of (a) individual complement components, (b) complement activation products, and (c) molecular mechanisms/function. An emerging area of major interest in translational studies aims to study and monitor patients on complement regulatory drugs for efficacy as well as adverse events. This area is progressing rapidly with several anti-complement therapeutics under development, in clinical trials, or already in clinical use. In this review, we summarized the appropriate indications, techniques, and interpretations of basic complement analyses, exemplified by a number of clinical disorders.Keywords
This publication has 50 references indexed in Scilit:
- Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMTFrontiers in Immunology, 2019
- Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic UseFrontiers in Immunology, 2019
- Interpretation of Serological Complement Biomarkers in DiseaseFrontiers in Immunology, 2018
- The renaissance of complement therapeuticsNature Reviews Nephrology, 2017
- Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4Proceedings of the National Academy of Sciences, 2017
- Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation BiomarkersAmerican Journal of Clinical Pathology, 2015
- Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-related Macular Degeneration and Normal EyesMolecular & Cellular Proteomics, 2010
- Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritisLupus, 2009
- Comparative study of circulating immune complexes quantity detection by three assays—CIF-ELISA, C1q-ELISA and anti-C3 ELISAJournal of Immunological Methods, 2001
- The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant ActivityJournal of Experimental Medicine, 1997